Founded in 1997, ERGOMED Group is dedicated to providing specialized services to the pharmaceutical and biotechnology industries, supporting the development of new drugs.
With a global footprint covering 100+ countries, we have the reach to deliver solutions for even the toughest clinical development and trial management challenges.
Ergomed has provided clinical development, pharmacovigilance, audit consulting services for 500+ clients, from top 10 pharmaceutical and generics organizations to small and mid-sized drug development companies.




Ergomed begins
First co-development deal
PrimeVigilance launches
Ergomed IPO
Aquisiton of Sound Opinion
Acquisition of Haemostatix
Acquisition of O+P, GASD
Acquisition of PharmInvent
Acquisition of PSR
Acquisition of Ashfield PV
Acquisition of MedSource
Integration of ADAMAS
Permira completes acquisition of Ergomed
Acquisition of Panacea
Integration of Prudentia Group
Acquisition of PhV Latam
Acquisition of Bloom Agents